BRCA2 and ovarian carcinoma: In addition to germline mutations, at least another 2–8 % of ovarian cancers have somatic BRCA1 and BRCA2 mutations [5], so that up to 20 % of patients with ovarian cancer have a BRCA1 or BRCA2 deficiency triggered by a mutation.